The Quantellect read.As of Nov 19, 2026, 6 active firms cover Petco Health and Wellness Company, Inc: 1 rate it Buy or better, 4 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets range widely, $2.11 to $5.00 (about 2.4x), a sign of real disagreement on valuation. The average target of $3.35 sits 23% above the current $2.73. Sentiment has cooled somewhat, with Sell ratings rising from 0 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.06 next quarter toward $0.27 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 active firms
Neutral
Strong Buy00%
Buy117%
Neutral467%
Sell117%
Strong Sell00%
Based on 6 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$3.35
+22.8% upside
Average target across 6 active firms as of Nov 19, 2026 vs $2.73 current
Highest Target$5.00
Average Target$3.35
Lowest Target$2.11
Detailed analyst forecasts for WOOF
Showing 1–6 of 6 named analysts shown · 6 active firms in the rating projection
As of Nov 19, 2026, 1 of 6 active firms rate WOOF a Buy (4 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
WOOF EPS & revenue forecast
EPS · NEXT QUARTER
$0.06
Range $0.02 – $0.08 · 7 analysts · +48% YoY
Next period, 7 analysts expect Petco Health and Wellness Company, Inc. to earn $0.06 a share (range $0.02 – $0.08), versus $0.04 a year earlier. Full-year consensus is $0.26, growing to $0.27 the year after.
REVENUE · NEXT QUARTER
$1.5B
Range $1.5B – $1.5B · 7 analysts · +1% YoY
Revenue is expected to reach $1.5B (range $1.5B – $1.5B), +1.0% year-over-year. Full-year consensus is $6.0B, rising to $6.1B next year.
Top analysts covering Petco Health and Wellness Company, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on WOOF.
#1
OW
Oliver Wintermantel
Evercore ISI Group
Neutral
$3.00+9.9% to target
Coverage
—
+ Follow
#2
Simeon Gutman
Morgan Stanley
Neutral
$3.75+37.4% to target
Coverage
—
+ Follow
#3
Steven Shemesh
RBC Capital
Buy
$4.00+46.5% to target
Coverage
—
+ Follow
#4
Michael Lasser
UBS
Neutral
$3.50+28.2% to target
Coverage
—
+ Follow
#5
Zachary Fadem
Wells Fargo
Neutral
$3.00+9.9% to target
Coverage
—
+ Follow
WOOF stock forecast FAQ
What is WOOF's average 12-month price target?+
The 6 active firms with a live target average $3.35 for Petco Health and Wellness Company, Inc. over the next 12 months, ranging from a $5.00 high to a $2.11 low, as of Nov 19, 2026.
Is WOOF stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 6 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 4 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for WOOF?+
The Street-high target is $5.00 (Jefferies), and the Street-low is $2.11 (BNP Paribas). The average of all 6 active-firm targets is $3.35.
How many active Wall Street firms cover WOOF?+
6 active firms have a recognized rating on Petco Health and Wellness Company, Inc. as of Nov 19, 2026, and 6 active firms carry a live 12-month price target.
Who is the most accurate analyst covering WOOF?+
Among analysts who currently cover WOOF, Oliver Wintermantel of Evercore ISI Group has the strongest overall Quantellect track record. Their current call is Neutral with a $3.00 target.
What is Petco Health and Wellness Company, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.06 per share (range $0.02 – $0.08) across 7 analysts. Full-year EPS is projected at $0.26, rising to $0.27 the following year.
How much revenue is Petco Health and Wellness Company, Inc. expected to report next quarter?+
Consensus revenue is $1.5B (range $1.5B – $1.5B). Full-year revenue is projected at $6.0B, growing to $6.1B next year.
Have analysts been upgrading or downgrading WOOF lately?+
As of Nov 19, 2026, 1 of 6 active firms rate WOOF a Buy (4 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their WOOF calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.